| Literature DB >> 18367534 |
Ronald S Veazey1, Paula M Acierno, Kimberly J McEvers, Susanne H C Baumeister, Gabriel J Foster, Melisa D Rett, Michael H Newberg, Marcelo J Kuroda, Kenneth Williams, Eun-Young Kim, Steven M Wolinsky, E Peter Rieber, Michael Piatak, Jeffrey D Lifson, David C Montefiori, Charles R Brown, Vanessa M Hirsch, Jörn E Schmitz.
Abstract
Previously we have shown that CD8(+) T cells are critical for containment of simian immunodeficiency virus (SIV) viremia and that rapid and profound depletion of CD4(+) T cells occurs in the intestinal tract of acutely infected macaques. To determine the impact of SIV-specific CD8(+) T-cell responses on the magnitude of the CD4(+) T-cell depletion, we investigated the effect of CD8(+) lymphocyte depletion during primary SIV infection on CD4(+) T-cell subsets and function in peripheral blood, lymph nodes, and intestinal tissues. In peripheral blood, CD8(+) lymphocyte-depletion changed the dynamics of CD4(+) T-cell loss, resulting in a more pronounced loss 2 weeks after infection, followed by a temporal rebound approximately 2 months after infection, when absolute numbers of CD4(+) T cells were restored to baseline levels. These CD4(+) T cells showed a markedly skewed phenotype, however, as there were decreased levels of memory cells in CD8(+) lymphocyte-depleted macaques compared to controls. In intestinal tissues and lymph nodes, we observed a significantly higher loss of CCR5(+) CD45RA(-) CD4(+) T cells in CD8(+) lymphocyte-depleted macaques than in controls, suggesting that these SIV-targeted CD4(+) T cells were eliminated more efficiently in CD8(+) lymphocyte-depleted animals. Also, CD8(+) lymphocyte depletion significantly affected the ability to generate SIV Gag-specific CD4(+) T-cell responses and neutralizing antibodies. These results reemphasize that SIV-specific CD8(+) T-cell responses are absolutely critical to initiate at least partial control of SIV infection.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18367534 PMCID: PMC2395171 DOI: 10.1128/JVI.02748-07
Source DB: PubMed Journal: J Virol ISSN: 0022-538X Impact factor: 5.103